Mean ovarian diameter (MOD) as a predictor of poor ovarian response

被引:2
|
作者
Vladimirov, IK [1 ]
Tacheva, DM
Kalinov, KB
机构
[1] Med Ctr St Pantailemon, Div Reprod Med, Sofia, Bulgaria
[2] New Bulgarian Univ, Dept Psychol & Cognit Sci, Sofia, Bulgaria
关键词
COH; IVF; logistic model; MOD; poor response;
D O I
10.1023/B:JARG.0000027017.32027.df
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: To determine the predictive value of mean ovarian diameter of ovarian response in controlled ovarian hyperstimulation (COH), in outcome with normal FSH level in early follicular phase of menstrual cycle. Methods: A prospective study established the prognostic value of the mean ovarian diameter of total 57 cases, including 17 patients undergoing IVF treatment with poor ovarian response and 40 patients ( control group) with adequate ovarian response. Results: The mean ovarian diameter ( MOD) of patients in the cancelled group was significantly lower (19.23 +/- 2.78) than in a comparable control group (24.67 +/- 3.38) [p < 0.001]. The mean ovarian diameter was a good predictor of poor ovarian response - area under receiver operating characteristic curve - ROCAUC = 0.88. The best criterion value discriminating between cancelled cycle and punctured was <= 20.6 mm. Conclusions: Our data demonstrate that the mean ovarian diameter provides good prognostic information in outcomes with poor ovarian response during controlled ovarian hyperstimulation in IVF. The test is easy to perform and it is a good informative resource.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [41] Involvement of single nucleotide polymorphisms in ovarian poor response
    Sayyed Mohammad Hossein Ghaderian
    Reza Akbarzadeh
    Saghar Salehpour
    Journal of Assisted Reproduction and Genetics, 2021, 38 : 2405 - 2413
  • [42] EFFICACY OF CONTROLLED OVARIAN STIMULATION IN BOTH FOLLICULAR AND LUTEAL PHASES FOR PATIENTS WITH POOR OVARIAN RESPONSE
    Liu, Y. F.
    Cheng, S. L.
    Wang, F.
    Huang, G. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (01): : 227 - 232
  • [43] Transvaginal ultrasound ovarian morphology: can it predict poor ovarian response to gonadotrophin stimulation in IVF?
    Khalifa, EE
    HUMAN REPRODUCTION, 1998, 13 : 39 - 40
  • [44] Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation
    Hanevik, Hans I.
    Hilmarsen, Hilde T.
    Skjelbred, Camilla F.
    Tanbo, Tom
    Kahn, Jarl A.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2014, 12
  • [45] Emerging follicular activation strategies to treat women with poor ovarian response and primary ovarian insufficiency
    Reig, Andres
    Herraiz, Sonia
    Pellicer, Antonio
    Seli, Emre
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (03) : 241 - 248
  • [46] Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation
    Hans I Hanevik
    Hilde T Hilmarsen
    Camilla F Skjelbred
    Tom Tanbo
    Jarl A Kahn
    Reproductive Biology and Endocrinology, 12
  • [47] A Case-Control Study of Sonographic Maximum Ovarian Diameter as a Predictor of Ovarian Torsion in Emergency Department Females With Pelvic Pain
    Budhram, Gavin
    Elia, Tala
    Dan, Jeff
    Schroeder, Michele
    Safain, Golien
    Schlech, Walter
    Friderici, Jennifer
    Knee, Alex
    Anthouard, Magalie
    Schoenfeld, Elizabeth
    ACADEMIC EMERGENCY MEDICINE, 2019, 26 (02) : 152 - 159
  • [48] The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
    A Popple
    L G Durrant
    I Spendlove
    P Rolland
    I V Scott
    S Deen
    J M Ramage
    British Journal of Cancer, 2012, 106 : 1306 - 1313
  • [49] The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
    Popple, A.
    Durrant, L. G.
    Spendlove, I.
    Rolland, P.
    Scott, I. V.
    Deen, S.
    Ramage, J. M.
    BRITISH JOURNAL OF CANCER, 2012, 106 (07) : 1306 - 1313
  • [50] A Poor Predictor in Ovarian Cancer Patients Treated with Taxane-Platinum Regimen
    Felisiak-Golabek, A.
    Rembiszewska, A.
    Szafron, L.
    Chodzynska, J.
    Kwiatkowska, E.
    Rzepecka, I.
    Dansonka-Mieszkowska, A.
    Podgorska, A.
    Kupryjanczyk, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 135 - 135